As of Jun 9, 2026, the Johnson & Johnson stock's PE ratio is 27.15. This takes into account the latest EPS of $8.73 and stock price of $237. The PE ratio marks an increase of 36% from its last 4 quarters average of 19.9.
The PE ratio of Johnson & Johnson has averaged 45.27 over the last ten years. The current P/E ratio of 27.15 is 40% lower than the historical average. Looking back at the last ten years, JNJ's PE ratio peaked in the Dec 2017 quarter at 291.08, when the price was $139.72 and the EPS was $0.48. The lowest point was in the Jun 2024 quarter, when it reached 9.6 with a price of $146.16 and an EPS of $15.23.
Maximum annual increase: 1,426.38% in 2017
Maximum annual decrease: -92.33% in 2018
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 18.65 | -24.92% | $207.63 | $11.13 |
| 2024 | 24.84 | 120.02% | $145.05 | $5.84 |
| 2023 | 11.29 | -56.34% | $156.74 | $13.88 |
| 2023 | 25.86 | 19.89% | $176.65 | $6.83 |
| 2022 | 21.57 | -23.37% | $171.07 | $7.93 |
| 2021 | 28.15 | 10.48% | $157.38 | $5.59 |
| 2019 | 25.48 | 14.11% | $145.75 | $5.72 |
| 2018 | 22.33 | -92.33% | $127.27 | $5.7 |
| 2017 | 291.08 | 1,426.38% | $139.72 | $0.48 |
| 2017 | 19.07 | 3.25% | $115.21 | $6.04 |
| 2016 | 18.47 | 1.99% | $102.72 | $5.56 |
| 2014 | 18.11 | -3.52% | $105.06 | $5.8 |
| 2013 | 18.77 | 6.47% | $92.35 | $4.92 |
| 2012 | 17.63 | -4.86% | $69.48 | $3.94 |
| 2012 | 18.53 | 45.33% | $65.58 | $3.54 |
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 27.54 | 47.67% | $240.45 | $8.73 |
| Dec 2025 | 18.65 | 8.24% | $207.63 | $11.13 |
| Sep 2025 | 17.23 | 6.36% | $179.71 | $10.43 |
| Jun 2025 | 16.2 | -10.35% | $152.41 | $9.41 |
| Mar 2025 | 18.07 | -27.25% | $163.71 | $9.06 |
| Dec 2024 | 24.84 | -7.21% | $145.05 | $5.84 |
| Sep 2024 | 26.77 | 178.85% | $161.4 | $6.03 |
| Jun 2024 | 9.6 | -7.43% | $146.16 | $15.23 |
| Mar 2024 | 10.37 | -8.15% | $158.19 | $15.26 |
| Dec 2023 | 11.29 | -1.31% | $156.74 | $13.88 |
| Oct 2023 | 11.44 | -65.51% | $155.75 | $13.61 |
| Jul 2023 | 33.17 | 3.59% | $165.52 | $4.99 |
| Apr 2023 | 32.02 | 23.82% | $155 | $4.84 |
| Jan 2023 | 25.86 | 15.55% | $176.65 | $6.83 |
| Oct 2022 | 22.38 | -12.85% | $163.36 | $7.3 |
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
JNJ's current PE ratio is higher than the 3 and 5-year averages, but it is lower than its 10-year average.
Johnson & Johnson's price to earnings (P/E) of 27.15 is higher than the Healthcare sector, the industry and its peers average. In comparison with the Healthcare sector average of 24.1, Johnson & Johnson's price to earnings (P/E) is 13% higher.
In comparison to its peers LLY and MRK, JNJ's PE ratio is lower, but it is higher than NVS's and ABT's. Johnson & Johnson's current PE ratio of 27.15 is similar to the average of its peers, which is 27.0.
| Stock name | PE ratio | Market cap |
|---|---|---|
| GILD Gilead Sciences Inc | 16.91 | $155.82B |
| PFE Pfizer Inc | 19.62 | $146.48B |
| NVS Novartis AG | 21.24 | $284.53B |
| MDT Medtronic plc | 22.77 | $105.25B |
| ABT Abbott Laboratories | 25.42 | $158.94B |
| JNJ Johnson & Johnson | 27.15 | $570.51B |
| MRK Merck & Co Inc | 33.5 | $295.39B |
| SYK Stryker Corp | 35.93 | $120.38B |
| LLY ELI LILLY & Co | 40.61 | $1.08T |
JNJ stock has a price to earnings ratio of 27.15 as of Jun 9, 2026.
The average PE ratio for JNJ stock over the past 3 years is 18.76.
The average PE ratio for JNJ stock over the past 5 years is 21.25.
Over the last ten years, the Dec 2017 quarter recorded the highest quarterly PE ratio at 291.08.
JNJ's price to earnings ratio is currently 40% below its 10-year historical average.
The P/E ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Jun 9, 2026), Johnson & Johnson's share price is $237. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $8.73. Therefore, Johnson & Johnson's PE ratio for today is 27.15. PE RATIO(27.15) = STOCK PRICE($237) / TTM EPS($8.73)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.